Header.png

Our mission is to save lives by bringing fast and actionable infectious disease diagnosis to primary care 

_edited.jpg

The need

  • Up to 20% of all primary care consultations are due to respiratory infections¹ ​​​

  • They result in 4 million deaths each year, almost all of them due to infections in the lower respiratory tract causing pneumonia²

  • Lack of good diagnostic solutions are a main reason for poor outcomes and antibiotic overuse

  • Transformative, rapid testing where people first seek care is needed to capture pneumonia early and initiate the right treatment

background2.png

Our solution 

A non-invasive sample-to-answer breath test that reliably detects multiple lower respiratory tract infections in primary care within minutes in three simple steps:

1. Collect

Breathe for

2 minutes

2. Detect

Diagnose

multiple diseases

3. Act

Take the right

action

The impact

  • Saving lives by earlier appropriate antibiotic or antiviral treatment and rapid patient referral

  • Reducing healthcare costs: Avelo's rapid test results help to lower the annual costs of USD 52 billion in Europe alone by keeping patients out of the hospital³

  • Fighting antimicrobial resistance (AMR): Avelo's test differentiates between viral and bacterial infections to assist in antibiotic stewardship and reduce the > 65% unnecessarily prescribed antibiotics in primary care⁴

  • Establishing self-collected breath bioaerosols as a novel diagnostic sample type for new testing solutions

iStock-865702322_edited.jpg
Contact

Headquarters:

Avelo Inc.

Dorfstrasse 46

CH-8102 Oberengstringen

Switzerland

+41 43 588 33 44

hello@avelolife.com

Research site:

Swiss Innovation Park
Gewerbestrasse 14

CH-4123 Allschwil

Switzerland

Social
SocialMedia_Linkedin.png

Copyright © 2021 by Avelo Inc. All rights reserved.